ADMAAdma Biologics Inc
ADMA
Adma Biologics Inc20,733
Mkt Cap
$2.19BVolume
6.13M52W High
$25.6752W Low
$7.21PE Ratio
15.34ADMA Fundamentals
Price
$9.19Prev Close
$9.11Open
$8.9050D MA
$14.96Beta
1.28Avg. Volume
8.9MEPS (Annual)
$0.60P/B
4.58Rev/Employee
$788,520.87$4,459.32
Janux Therapeutics Secures $35M Milestone Payment From BMY Deal
JANX earns $35M milestone payment from Bristol Myers as TRACTr-based cancer candidate advances, signaling progress in its tumor-activated therapy platform.
Zacks·2d ago
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA
INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA INVESTOR ALERT: Pomerantz Law Firm Investigates Claims On Behalf of Investors of ADMA Biologics, Inc. - ADMA PR Newswire NEW YORK, April 2, 2026 NEW YORK, April 2, 2026 /PRNewswire...
PR Newswire·2d ago
ADMA INVESTOR ALERT: Kirby McInerney LLP Investigates Potential Claims Involving ADMA Biologics, Inc.
The law firm of Kirby McInerney LLP continues its investigation on behalf of ADMA Biologics, Inc. (ADMA or the Company) (NASDAQ:ADMA) investors concerning the Companys and/or members of its senior managements possible violation of the federal securities laws and other unlawful business practices...
Business Wire·3d ago
Will Lead Drug Asceniv Fuel ADMA's Top-Line Growth in 2026?
ADMA rides on surging Asceniv demand, expanding payer coverage, and stronger plasma supply deals to drive rapid revenue growth through 2027.
Zacks·3d ago
NVO Launches Wegovy Subscription Plan, Boosts Access, Stock Up
Novo Nordisk stock jumps after launching a Wegovy subscription plan to cut costs, expand telehealth access and improve treatment adherence for sustained obesity care.
Zacks·3d ago
Biogen to Acquire Apellis for $5.6B to Strengthen Immunology Portfolio
BIIB's $5.6B offer to acquire APLS is set to add two key immunology drugs, boosting near-term revenues and strengthening its push into high-growth rare disease markets.
Zacks·3d ago
ADMA Investor Alert: ADMA Biologics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Revenue Headwinds: Levi & Korsinsky
ADMA Investor Alert: ADMA Biologics Securities Fraud Lawsuit - Investors With Losses May Seek to Lead the Class Action After Company Allegedly Concealed Revenue Headwinds: Levi & Korsinsky ADMA...
PR Newswire·4d ago
Adma Biologics (ADMA) Stock Declines While Market Improves: Some Information for Investors
The latest trading day saw Adma Biologics (ADMA) settling at $9.01, representing a -1.53% change from its previous close.
Zacks·4d ago
ADMA Securities News: ADMA Biologics Investigated for Securities Fraud After Culper Research Report Revelation Sparks 29% Stock Drop
ADMA Securities News: ADMA Biologics Investigated for Securities Fraud After Culper Research Report Revelation Sparks 29% Stock Drop ADMA Securities News: ADMA Biologics Investigated for Securities...
PR Newswire·5d ago
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating
ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller Claims Points to Improper Channel Stuffing, Hagens Berman Investigating ADMA Biologics, Inc. (ADMA) Crashes 16% Amid Scrutiny Over Skyrocketing Days Sales Outstanding That Short Seller...
PR Newswire·5d ago
<
1
2
...
>